Bobby Brooke Herrera

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

Viruses

Pathogens (Basel, Switzerland)

PLoS neglected tropical diseases

Harvard T.H. Chan School of Public Health

Harvard University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Harvard T.H. Chan School of Public Health Jan 15 2019

United States

Visiting Scientist :: Immunology and Infectious Diseases

E25Bio, Inc. Jun 01 2018

United States

CEO

Harvard Medical School

United States

Post-doctoral fellow :: Immunobiology

Harvard University Jul 01 2015

United States

Graduate Student :: Immunology of Infectious Diseases

Massachusetts General Hospital Jul 01 2013 - Jul 01 2015

United States

Research Technician II :: Infectious Diseases

Harvard University Jul 01 2012 - Jul 01 2013

United States

Research Fellow :: Research Scholar Initiative Post-baccalaureate Program

Johns Hopkins Bloomberg School of Public Health May 31 2012 - Jul 01 2012

United States

Research Fellow :: Immunology

New Mexico State University May 01 2010 - May 30 2012

United States

NIH MARC Undergraduate Research Fellow :: Biology

Education History

Harvard University

United States

PHD :: Immunology of Infectious Diseases

Publications

Reem Alatrash, Bobby Brooke Herrera
The Adaptive Immune Response against Bunyavirales . Viruses 16 (3) (2024)
Reem Alatrash, Bobby Brooke Herrera
The Adaptive Immune Response against Bunyavirales . Viruses 16 (3) (2024)
Reem Alatrash, Bobby Brooke Herrera
The Adaptive Immune Response against Bunyavirales . Viruses 16 (3) (2024)
Reem Alatrash, Bobby Brooke Herrera
The Adaptive Immune Response against Bunyavirales . Viruses 16 (3) (2024)
Julie Joseph, Grace Sandel, Ratuja Kulkarni, Reem Alatrash, Bobby Brooke Herrera, Zafar K Khan
Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS. Pathogens (Basel, Switzerland) 13 (1) (2023)
Julie Joseph, Grace Sandel, Ratuja Kulkarni, Reem Alatrash, Bobby Brooke Herrera, Zafar K Khan
Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS. Pathogens (Basel, Switzerland) 13 (1) (2023)
Julie Joseph, Grace Sandel, Ratuja Kulkarni, Reem Alatrash, Bobby Brooke Herrera, Zafar K Khan
Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS. Pathogens (Basel, Switzerland) 13 (1) (2023)
Julie Joseph, Grace Sandel, Ratuja Kulkarni, Reem Alatrash, Bobby Brooke Herrera, Zafar K Khan
Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS. Pathogens (Basel, Switzerland) 13 (1) (2023)
Bobby Brooke Herrera, Rafaela Mayoral, Carlos Brites
Development and Validation of a Rapid Screening Test for HTLV-I IgG Antibodies. Viruses 15 (1) (2022)
Bobby Brooke Herrera, Rafaela Mayoral, Carlos Brites
Development and Validation of a Rapid Screening Test for HTLV-I IgG Antibodies. Viruses 15 (1) (2022)
Nol Salcedo, Ankita Reddy, Adam R Gomez, Irene Bosch, Bobby Brooke Herrera
Monoclonal antibody pairs against SARS-CoV-2 for rapid antigen test development. PLoS neglected tropical diseases 16 (3) (2022)
Bobby Brooke Herrera, Rafaela Mayoral, Carlos Brites
Development and Validation of a Rapid Screening Test for HTLV-I IgG Antibodies. Viruses 15 (1) (2022)
Ankita Reddy, Irene Bosch, Nol Salcedo, Bobby Brooke Herrera, Helena de Puig, Carlos F Narvaez, Diana María Caicedo-Borrero, Ivette Lorenzana, Leda Parham, Kimberly F Garcia, Marcela Mercado, Angélica María Rico Turca, Luis A Villar-Centeno, Margarita Gélvez-Ramírez, Natalia Andrea Gómez Ríos, Megan Hiley, Dawlyn García, Michael S Diamond, Lee Gehrke
Development and Validation of a Rapid Lateral Flow E1/E2-Antigen Test and ELISA in Patients Infected with Emerging Asian Strain of Chikungunya Virus in the Americas. Viruses 12 (9) (2020)

Bobby Brooke Herrera.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bobby Brooke Herrera